Health Care [ 3/12 ] | Health Care Technology [ 15/74 ]
NASDAQ | Common Stock
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America.
The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team.
It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization.
In addition, the company provides auditing and coding, software, and professional services.
The company sells its solutions and services through direct sales force and reseller partnerships.
Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 12, 24 | -0.61 Decreased by -2.95 K% | -0.03 Decreased by -1.93 K% |
| Sep 11, 24 | -0.05 Decreased by -25.00% | -0.04 Decreased by -25.00% |
| Jun 11, 24 | -0.05 Increased by 0.00% | -0.04 Decreased by -25.00% |
| Apr 30, 24 | -0.02 Increased by +50.00% | -0.04 Increased by +50.00% |
| Dec 13, 23 | -0.02 Increased by +71.43% | -0.04 Increased by +50.00% |
| Sep 13, 23 | -0.04 Increased by +42.86% | -0.05 Increased by +20.00% |
| Jun 12, 23 | -0.05 Increased by +16.67% | -0.05 |
| Apr 26, 23 | -0.04 Decreased by -60.00% | -0.05 Increased by +20.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Oct 31, 24 | 4.42 B Increased by +71.95 K% | -2.48 B Decreased by -20.69 K% | Decreased by -56.03% Increased by +71.15% |
| Jul 31, 24 | 4.48 M Decreased by -22.43% | -2.80 M Decreased by -11.45% | Decreased by -62.62% Decreased by -43.67% |
| Apr 30, 24 | 4.33 M Decreased by -18.79% | -2.74 M Increased by +5.58% | Decreased by -63.26% Decreased by -16.26% |
| Jan 31, 24 | 5.36 M Decreased by -20.52% | -1.37 M Increased by +37.21% | Decreased by -25.55% Increased by +21.00% |
| Oct 31, 23 | 6.13 M Decreased by -1.35% | -11.91 M Decreased by -279.57% | Decreased by -194.21% Decreased by -284.77% |
| Jul 31, 23 | 5.77 M Decreased by -3.70% | -2.52 M Increased by +23.14% | Decreased by -43.59% Increased by +20.18% |
| Apr 30, 23 | 5.33 M Decreased by -10.16% | -2.90 M Decreased by -4.09% | Decreased by -54.41% Decreased by -15.86% |
| Jan 31, 23 | 6.75 M Increased by +11.56% | -2.18 M Decreased by -7.17 K% | Decreased by -32.35% Decreased by -6.42 K% |